Consistent with METTL5 knockdown, SAC treatment induced a significant decrease in global protein translation efficiency, as well as SEPHS2, GPX4, and full-length PARP1 protein levels in treated MM cells (Fig. 7I). This evidence concerns the gene PARP1 and Miyoshi myopathy.